The quarter fell short of the market’s operating bar. Published estimates were roughly $308.8 million of revenue and $1.06 of adjusted EPS; Ziff Davis delivered $286.7 million and $1.03, respectively.
| Metric | Q2 2026 | Q2 2025 / expectation | Read |
|---|---|---|---|
| Revenue | $286.7M | $294.8M / ~$308.8M consensus | Down 2.7%; about 7% below consensus (Financial Highlights) |
| Adjusted EBITDA | $76.8M | $79.8M | Down 3.7%; margin fell to 26.8% from 27.1% (Financial Highlights) |
| Adjusted diluted EPS | $1.03 | $0.91 / ~$1.06 consensus | Year-over-year increase, but modestly below consensus (Financial Highlights) |
| Net cash from operations | $89.0M | $57.1M | Up 55.9%, though includes discontinued operations (Cash Flow statement) |
| Free cash flow | $54.0M | $26.9M | Up 100.3%, though includes discontinued operations (Free Cash Flow reconciliation) |
The underlying revenue trend is weaker than the headline EPS suggests. Continuing-operations revenue declined in Technology & Shopping and Health & Wellness, while advertising retention fell to 90.0% from 95.0% and to 99.8% from 97.4%, respectively. Gaming advertising retention also dropped sharply to 81.6% from 93.7%; its higher customer count did not offset lower revenue per customer (Key Operating Metrics by Segment — Advertising and Performance Marketing). Subscription customers declined materially in Health & Wellness, from 1.892 million to 1.618 million, while Cybersecurity & Martech was essentially flat (Key Operating Metrics by Segment — Subscription and Licensing).
The goodwill impairment is non-cash, but it is still an important warning about Health & Wellness. The company recorded a $54.8 million impairment in that segment, which pushed GAAP operating income to a $44.7 million loss from $13.8 million of profit a year earlier. Excluding the impairment, adjusted EBITDA still fell in Health & Wellness to $30.2 million from $33.4 million, and the segment’s margin fell to 31.9% from 33.6% (Segment results — Health & Wellness; Income Statement).
The Connectivity sale materially improved liquidity but does not repair the continuing business. Ziff Davis received approximately $1.134 billion net of cash divested and ended the quarter with $1.606 billion of cash against $872 million of gross debt, or $734 million of net cash (Capital Structure; Cash Flow statement). The transaction was already part of the company’s strategic process, so completion is more balance-sheet relief than a fresh operating beat. Cash flow also benefited from discontinued operations and should not be treated as recurring cash generation from the remaining segments (Cash Flow statement).
Net read: the financial flexibility is better, but the operating result missed expectations and the core portfolio is deteriorating. The cash proceeds, share repurchases, and stronger reported free cash flow soften the impact, yet the revenue miss, weaker advertising retention, declining Health & Wellness subscribers, and impairment point to a business that is underperforming the market’s assumptions. No new operating guidance was disclosed in the filing.
Read the original 8-K on SEC EDGAR ↗